BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25590580)

  • 1. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
    Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
    Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.
    Shi J; Qu Y; Li X; Sui F; Yao D; Yang Q; Shi B; Ji M; Hou P
    Cell Death Dis; 2016 Oct; 7(10):e2442. PubMed ID: 27787520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 5. PTP1B expression contributes to gastric cancer progression.
    Wang J; Liu B; Chen X; Su L; Wu P; Wu J; Zhu Z
    Med Oncol; 2012 Jun; 29(2):948-56. PubMed ID: 21442314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT.
    Liu X; Chen Q; Hu XG; Zhang XC; Fu TW; Liu Q; Liang Y; Zhao XL; Zhang X; Ping YF; Bian XW
    Tumour Biol; 2016 Oct; 37(10):13479-13487. PubMed ID: 27465552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.
    Su YL; Luo HL; Huang CC; Liu TT; Huang EY; Sung MT; Lin JJ; Chiang PH; Chen YT; Kang CH; Cheng YT
    Cells; 2020 Mar; 9(4):. PubMed ID: 32225123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
    Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
    World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
    Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer.
    Shi J; Liu W; Sui F; Lu R; He Q; Yang Q; Lv H; Shi B; Hou P
    Oncotarget; 2015 Jun; 6(16):14344-59. PubMed ID: 25970779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatase 1B regulates the activity of retinal pigment epithelial cells.
    Du ZD; Hu LT; Zhao GQ; Li Y; Ma ZZ
    Mol Vis; 2015; 21():523-31. PubMed ID: 25999679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
    Yan K; Tian J; Shi W; Xia H; Zhu Y
    Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-146b Regulates Cell Proliferation and Apoptosis in Gastric Cancer by Targeting PTP1B.
    Xu J; Zhang Z; Chen Q; Yang L; Yin J
    Dig Dis Sci; 2020 Feb; 65(2):457-463. PubMed ID: 31441000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
    Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
    Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt.
    Ye Y; Ge YM; Xiao MM; Guo LM; Li Q; Hao JQ; Da J; Hu WL; Zhang XD; Xu J; Zhang LJ
    J Gastroenterol; 2016 Mar; 51(3):230-40. PubMed ID: 26201869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer.
    Song YA; Park YL; Kim KY; Myung E; Chung CY; Cho SB; Lee WS; Jung YD; Kweon SS; Joo YE
    Pathol Int; 2012 Feb; 62(2):127-36. PubMed ID: 22243783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.